Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques

Autor: Michael J. Ricciardi, Diogo M. Magnani, Cassia G. T. Silveira, Sherrie Jean, David E. Lee, Dennis R. Burton, Elizabeth Strobert, Lucas Gonzalez-Nieto, Nathan D. Grubaugh, Aline Domingues, Myrna C. Bonaldo, Guido Silvestri, Varian K. Bailey, Devin Sok, Khoa Le, Esper G. Kallas, Bryan Briney, Ann Chahroudi, Thomas H. Vanderford, Nathan Beutler, David I. Watkins, Thomas F. Rogers, Nuria Pedreño-Lopez, Erica E. Okwuazi, Stephen S. Whitehead, Mauricio A. Martins, Martin J. Gutman, Alexander Strubel, Helen S. Maxwell, Ronald C. Desrosiers
Rok vydání: 2017
Předmět:
Zdroj: Science Translational Medicine. 9
ISSN: 1946-6242
1946-6234
Popis: Therapies to prevent maternal Zika virus (ZIKV) infection and its subsequent fetal developmental complications are urgently required. We isolated three potent ZIKV-neutralizing monoclonal antibodies (nmAbs) from the plasmablasts of a ZIKV-infected patient—SMZAb1, SMZAb2, and SMZAb5—directed against two different domains of the virus. We engineered these nmAbs with Fc LALA mutations that abrogate Fc-gamma receptor (FcγR) binding, thus eliminating potential therapy-mediated antibody-dependent enhancement (ADE). We administered a cocktail of these three nmAbs to nonhuman primates (NHP) one day before challenge with ZIKV and demonstrated that the nmAbs completely prevented viremia in serum following challenge. Given that numerous Abs have exceptional safety profiles in humans, the cocktail described here could be rapidly developed to protect uninfected pregnant women and their fetuses.
Databáze: OpenAIRE